宋 碧姍

Medicine & Life Sciences

1. Stroke 100%
2. Dementia 55%
3. Cohort Studies 29%
4. Alzheimer Disease 26%
5. Parkinson Disease 26%
6. Cerebral Hemorrhage 22%
7. Cortical Synchronization 20%
8. Population 20%
9. Caregivers 17%
10. Thrombectomy 15%
11. Traumatic Brain Injury 14%
12. Seizures 14%
13. Neurogenesis 14%
14. Drug Resistant Epilepsy 14%
15. Brain Diseases 14%
16. Registries 12%
17. Epilepsy 12%
18. Chronic Kidney Failure 12%
19. Familial spinal arachnoiditis 11%
20. sodium metabisulfite 11%
21. Telmisartan 11%
22. Comorbidity 10%
23. Tolosa-Hunt Syndrome 10%
24. Cerebral Small Vessel Diseases 10%
25. Brain 10%
26. Accidental Falls 10%
27. Tissue Plasminogen Activator 9%
28. Confidence Intervals 9%
29. Leukoaraiosis 9%
30. Mortality 9%
31. Head 9%
32. coenzyme Q10 9%
33. Memantine 9%
34. Sensorimotor Cortex 9%
35. Neuropsychiatry 9%
36. Therapeutics 9%
37. Peroxisome Proliferator-Activated Receptors 8%
38. Pyridoxine 8%
39. Aged, 80 and over 8%
40. Middle Cerebral Artery 8%
41. Intracranial Hemorrhages 8%
42. Guaiacol 8%
43. Meningoencephalitis 8%
44. Pioglitazone 8%
45. Program Development 7%
46. Kidney 7%